| Product Code: ETC9557646 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Ischemic Heart Disease Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Ischemic Heart Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Ischemic Heart Disease Market - Industry Life Cycle |
3.4 Sweden Ischemic Heart Disease Market - Porter's Five Forces |
3.5 Sweden Ischemic Heart Disease Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Sweden Ischemic Heart Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
4 Sweden Ischemic Heart Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as obesity, diabetes, and hypertension leading to ischemic heart disease |
4.2.2 Technological advancements in diagnostic tools and treatment options for ischemic heart disease |
4.2.3 Growing aging population in Sweden leading to a higher incidence of ischemic heart disease |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new therapies or medical devices for ischemic heart disease |
4.3.2 High cost associated with advanced treatment options for ischemic heart disease |
4.3.3 Limited healthcare infrastructure or resources in certain regions of Sweden affecting access to quality care for ischemic heart disease patients |
5 Sweden Ischemic Heart Disease Market Trends |
6 Sweden Ischemic Heart Disease Market, By Types |
6.1 Sweden Ischemic Heart Disease Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Sweden Ischemic Heart Disease Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Sweden Ischemic Heart Disease Market Revenues & Volume, By Angina Pectoris, 2021- 2031F |
6.1.4 Sweden Ischemic Heart Disease Market Revenues & Volume, By Myocardial Infarction, 2021- 2031F |
6.2 Sweden Ischemic Heart Disease Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Sweden Ischemic Heart Disease Market Revenues & Volume, By Anti-Dyslipidemic Drugs, 2021- 2031F |
6.2.3 Sweden Ischemic Heart Disease Market Revenues & Volume, By Beta-Blockers, 2021- 2031F |
6.2.4 Sweden Ischemic Heart Disease Market Revenues & Volume, By ACE Inhibitors, 2021- 2031F |
6.2.5 Sweden Ischemic Heart Disease Market Revenues & Volume, By ARBs, 2021- 2031F |
6.2.6 Sweden Ischemic Heart Disease Market Revenues & Volume, By Vasodilators, 2021- 2031F |
6.2.7 Sweden Ischemic Heart Disease Market Revenues & Volume, By Antithrombotic Agents, 2021- 2031F |
7 Sweden Ischemic Heart Disease Market Import-Export Trade Statistics |
7.1 Sweden Ischemic Heart Disease Market Export to Major Countries |
7.2 Sweden Ischemic Heart Disease Market Imports from Major Countries |
8 Sweden Ischemic Heart Disease Market Key Performance Indicators |
8.1 Average wait time for patients to undergo diagnostic tests or procedures related to ischemic heart disease |
8.2 Percentage of ischemic heart disease patients receiving guideline-recommended treatments |
8.3 Rate of hospital readmissions for ischemic heart disease patients within a specified time period |
9 Sweden Ischemic Heart Disease Market - Opportunity Assessment |
9.1 Sweden Ischemic Heart Disease Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Sweden Ischemic Heart Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10 Sweden Ischemic Heart Disease Market - Competitive Landscape |
10.1 Sweden Ischemic Heart Disease Market Revenue Share, By Companies, 2024 |
10.2 Sweden Ischemic Heart Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here